National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

NAE inhibitor MLN4924
A small molecule inhibitor of Nedd8 activating enzyme (NAE) with potential antineoplastic activity. NAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival. NAE activates Nedd8 (Neural precursor cell expressed, developmentally down-regulated 8), an ubiquitin-like (UBL) protein that modifies cellular targets in a pathway that is parallel to but distinct from the ubiquitin-proteasome pathway (UPP). Functioning in diverse regulatory activities, proteins conjugated to UBLs like Nedd8 typically are not targeted for proteasomal degradation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Nedd8-activating enzyme inhibitor MLN4924
Code name:MLN4924



Previous:N-methylformamide, N-phosphonacetyl-L-aspartate, NA17-A antigen, nabilone, nadroparin calcium
Next:nafoxidine hydrochloride, naloxone hydrochloride, naltrexone hydrochloride, Namenda, nandrolone decanoate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov